SESSION: CLINICAL STUDIES
10.00 - 12.00
SESSION: CLINICAL STUDIES
Chairpersons: Prof. Wojciech Jurczak, Dr Marek Dudziński
Chairpersons: Prof. Wojciech Jurczak, Dr Marek Dudziński
10.00 - 10.15
Rola Agencji Badań Medycznych w rozwoju badań klinicznych w Polsce | Dominika Substelny
10.15 - 10.30
PARTNER LECTURE 
Pratia – where clinical trials work | Małgorzata Gerjatowicz
Pratia – where clinical trials work | Małgorzata Gerjatowicz
10.30 - 10.45
PARTNER LECTURE .png)
The hospital knows more than it can find. An innovative AI-powered system for automatic identification of patients for clinical trials in hospital databases | Marek Dudziński, PhD
The hospital knows more than it can find. An innovative AI-powered system for automatic identification of patients for clinical trials in hospital databases | Marek Dudziński, PhD
10.45 - 11.00
GUEST LECTURE 
Poland as a partner in global clinical development in hemato-oncology – romaciclib case study (RVU120) | Kamil Sitarz, PhD
Poland as a partner in global clinical development in hemato-oncology – romaciclib case study (RVU120) | Kamil Sitarz, PhD
11.00 - 11.15
PARTNER LECTURE 
Bexobrutideg (NX-5948), a novel BTK degrader, in R/R CLL: ongoing and planned clinical trials | Matt Yates, PhD
Bexobrutideg (NX-5948), a novel BTK degrader, in R/R CLL: ongoing and planned clinical trials | Matt Yates, PhD
(ecture in English, translation is available)
11.15 - 12.00
Discussion
Dominika Substelny; Małgorzata Gerjatowicz; dr Marek Dudziński; dr Kamil Sitarz; Matt Yates, PhD; prof. Wojciech Jurczak
Dominika Substelny; Małgorzata Gerjatowicz; dr Marek Dudziński; dr Kamil Sitarz; Matt Yates, PhD; prof. Wojciech Jurczak
CLINICAL STUDY SESSION PARTNER
